ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

<p><strong>Objectives</strong></p> <p>The use of aspirin for the secondary prevention of cardiovascular disease (CVD) is firmly established, and the proportional reductions in heart attacks and strokes appear to be similar in people with and without diabetes. Uncertaint...

書誌詳細
主要な著者:	Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group
フォーマット:	Journal article
出版事項:	Elsevier 2017

類似資料

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
著者:: Parish, S, 等
出版事項: (2022)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
著者:: Emily L. Sammons, 等
出版事項: (2024-11-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
著者:: Sarah Parish, 等
出版事項: (2023-03-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
著者:: Sammons, E, 等
出版事項: (2024)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
著者:: Sammons, E, 等
出版事項: (2023)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
著者:: Sammons, E, 等
出版事項: (2023)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
著者:: Emily Sammons, 等
出版事項: (2023-10-01)

Effects of aspirin for primary prevention in persons with diabetes mellitus
著者:: Bowman, L, 等
出版事項: (2018)

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
著者:: Aung, T, 等
出版事項: (2016)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
著者:: Parish, S, 等
出版事項: (2023)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
著者:: Sammons, EL, 等
出版事項: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
著者:: Sammons, EL, 等
出版事項: (2024)

Effects of omega−3 fatty acid supplements on arrhythmias
著者:: Parish, S, 等
出版事項: (2020)

Aspirin for primary prevention of vascular disease in people with diabetes.
著者:: Haynes, R, 等
出版事項: (2009)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
著者:: Petrucci, G, 等
出版事項: (2024)

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes
著者:: Praveen Patel, 等
出版事項: (2025-02-01)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
著者:: Mafham, MM, 等
出版事項: (2019)

The ASCEND-Eye study: effect(s) of aspirin and omega-3 fatty acids on eye disease
著者:: Sammons, E
出版事項: (2023)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
著者:: Aung, T, 等
出版事項: (2017)

Effects of n-3 fatty acid supplements in diabetes mellitus
著者:: Ascend Study Collaborative Group, 等
出版事項: (2018)

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
著者:: Rocca, B, 等
出版事項: (2020)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
著者:: Harper, C, 等
出版事項: (2021)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
著者:: Harper, C, 等
出版事項: (2021)

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
著者:: Andrea K Viecelli, 等
出版事項: (2019-01-01)

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
著者:: Keng, MJ, 等
出版事項: (2021)

Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
著者:: Prathyusha Rampally, 等
出版事項: (2019-01-01)

Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion
著者:: Filip Hromcik, 等
出版事項: (2021-06-01)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
著者:: Hartweg, J, 等
出版事項: (2008)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
著者:: Hartweg, J, 等
出版事項: (2008)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
著者:: Eugene Han, 等
出版事項: (2016-01-01)

Synergistic effects of omega-3 polyunsaturated fatty acids and aspirin in the clinical practice – a narrative review
著者:: Zajac-Grabiec Anna, 等
出版事項: (2024-03-01)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
著者:: Leila Azadbakht, 等
出版事項: (2011-01-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
著者:: Price, H, 等
出版事項: (2009)

Aspirin for primary prevention of cardiovascular disease in diabetes
著者:: Ying Xing, 等
出版事項: (2019-07-01)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
著者:: Emberson, JR, 等
出版事項: (2007)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
著者:: Cull, C, 等
出版事項: (2004)

Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
著者:: Tajuddin N, 等
出版事項: (2016-04-01)

Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients
著者:: Pasquale Mone, 等
出版事項: (2022-03-01)

The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study
著者:: Ebrahim Shakiba, 等
出版事項: (2024-11-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
著者:: Collins, R, 等
出版事項: (1996)